Agfa to acquire EU contrast developer for nearly $15M

Justine Varieur Cadet | | Health Exec | EMR/EHR
Agfa HealthCare, a provider of diagnostic imaging and health IT solutions, has signed an agreement with Curagita Holding to acquire all the shares of its subsidiary Insight Agents, a European developer of contrast media, with business activities mainly in Germany.

The final acquisition price is expected to be around EUR10 million ($14.97 million U.S.).

According to Agfa, contrast media are primarily used with x-rays, CT scans and MRI, either to highlight anatomical structures (mostly vessels) or to perform functional imaging. “The decision to purchase a new line of business was made to ensure that we continue to offer a range of diagnostic imaging products over which we have full control,” said Dirk Debusscher, vice president of imaging at Agfa.

The companies said they are working “diligently” to close the transaction by the end of 2009.

Justine Varieur Cadet

Related Content

Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care
How are the best in KLAS Health IT vendor rankings created?

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup